David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GPOR
526
DELISTED
Gulfport Energy Corp.
GPOR
| $25.2M | 0.04% |
549,790
+124,447
| +29% | +$5.26M |
|
527
Ralph Lauren
RL
$21.6B
| $25M | 0.04% |
190,475
+182,191
| +2,199% | +$27M |
|
|
RTN
528
PUT
DELISTED
Raytheon Company
RTN
| $25M | 0.04% |
229,200
-190,600
| -45% | -$20.5M |
|
529
PG&E
PCG
$40.4B
| $24.9M | 0.04% |
468,869
-620,505
| -57% | -$34.3M |
|
530
Chubb
CB
$132B
| $24.9M | 0.04% |
223,087
+217,335
| +3,778% | +$24.4M |
|
531
CALL
Blackrock
BLK
$182B
| $24.8M | 0.04% |
67,700
-43,200
| -39% | -$15.7M |
|
|
WFM
532
PUT
DELISTED
Whole Foods Market Inc
WFM
| $24.6M | 0.04% |
473,000
-1,008,700
| -68% | -$54.1M |
|
533
Canadian Imperial Bank of Commerce
CM
$108B
| $24.6M | 0.04% |
677,344
+658,396
| +3,475% | +$24.4M |
|
534
PUT
UnitedHealth
UNH
$356B
| $24.5M | 0.04% |
207,100
+61,200
| +42% | +$6.8M |
|
535
CALL
Wells Fargo
WFC
$256B
| $24.4M | 0.04% |
448,900
-137,500
| -23% | -$7.43M |
|
|
GMCR
536
DELISTED
KEURIG GREEN MTN INC
GMCR
| $24.1M | 0.04% |
216,106
-106,289
| -33% | -$13.3M |
|
|
ALTR
537
DELISTED
Altera Corp
ALTR
| $24.1M | 0.04% |
561,897
+543,964
| +3,033% | +$19.5M |
|
|
LNKD
538
CALL
DELISTED
LinkedIn Corporation
LNKD
| $24M | 0.04% |
96,200
-65,600
| -41% | -$16.3M |
|
|
DNR
539
DELISTED
Denbury Resources, Inc.
DNR
| $23.8M | 0.04% |
3,268,623
+3,059,267
| +1,461% | +$23.7M |
|
|
EQC
540
DELISTED
Equity Commonwealth
EQC
| $23.8M | 0.04% |
895,911
+175,659
| +24% | +$4.61M |
|
|
PCYC
541
DELISTED
PHARMACYCLICS INC
PCYC
| $23.8M | 0.04% |
92,894
+56,665
| +156% | +$10.9M |
|
|
BID
542
DELISTED
Sotheby's
BID
| $23.7M | 0.04% |
561,202
+437,600
| +354% | +$18.7M |
|
543
CALL
Wynn Resorts
WYNN
$10.2B
| $23.6M | 0.04% |
187,200
-77,500
| -29% | -$11.1M |
|
|
LNW
544
DELISTED
Light & Wonder
LNW
| $23.4M | 0.04% |
2,237,731
+358,082
| +19% | +$4.52M |
|
|
PHH
545
DELISTED
PHH Corporation
PHH
| $23.3M | 0.04% |
962,529
+372,855
| +63% | +$9.01M |
|
546
Timken Company
TKR
$8.48B
| $23.1M | 0.04% |
548,267
+328,111
| +149% | +$13.6M |
|
547
PUT
Medtronic
MDT
$117B
| $23.1M | 0.04% |
295,955
-124,645
| -30% | -$9.45M |
|
548
PUT
Markel Group
MKL
$22.4B
| $23.1M | 0.04% |
30,000
+20,000
| +200% | +$14.5M |
|
549
Xylem
XYL
$26.3B
| $23.1M | 0.04% |
658,213
-341,787
| -34% | -$12.1M |
|
550
CALL
Mastercard
MA
$525B
| $23M | 0.04% |
266,700
+27,500
| +11% | +$2.39M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.